Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes

被引:17
|
作者
El-Ashmawy, Hazem M. [1 ]
Ahmed, Azza M. [2 ]
机构
[1] Zagazig Univ, Fac Med, Dept Internal Med, Zagazig, Egypt
[2] Zagazig Univ, Fac Med, Dept Clin Pathol, Zagazig, Egypt
关键词
fetuin-B; nonalcoholic fatty liver disease; type 2 diabetes mellitus; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; A LEVELS; RISK; ATHEROSCLEROSIS; STEATOHEPATITIS; INFLAMMATION; ASSOCIATION; GLUCOSE;
D O I
10.1097/MEG.0000000000001354
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Previous studies have assessed serum fetuin-B and its relation to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) and as a link between them through inducing insulin resistance (IR). Therefore, we examined the potential of serum fetuin-B to be an independent marker for NAFLD in patients with T2DM. Patients and methods The study group consisted of 270 patients with T2DM. Clinical and laboratory features were evaluated. The NAFLD severity was graded by ultrasound into three subgroups: grade 0 (no fatty liver), grade 1 (mild fatty liver), and grade 2-3 (medium to severe fatty liver). Fetuin-B, retinol-binding protein-4, and adiponectin were measured. Results Patients with grade 2-3 NAFLD had high fetuin-B levels in comparison with non-NAFLD group. Age and sex adjusted fetuin-B demonstrated positive correlations with triglycerides, gamma-glutamyl transferase, fasting plasma glucose, 2-h postprandial plasma glucose, homeostasis model assessment of IR, fasting insulin, glycated hemoglobin, high-sensitivity C-reactive protein, and estimated glomerular filtration rate, but it had a negative correlation with serum creatinine. Adiponectin level was decreased with increasing NAFLD severity, but no difference was found in retinol-binding protein-4. The estimated odds ratio (OR) for the occurrence of grade 2-3 NAFLD was increased significantly with increasing levels of fetuin-B (OR: 3.92; 95% confidence interval: 2.14-8.32 vs. OR: 8.91; 95% confidence interval: 4.22-18.41). The OR of fetuin-B in the uppermost tertile group was still significant after controlling for homeostasis model assessment of IR, glycated hemoglobin, waist circumference, BMI, hepatic enzymes, high-density lipoprotein cholesterol, triglycerides, and high-sensitivity C-reactive protein. Conclusions Our study demonstrated that serum fetuin-B had an independent association with NAFLD in patients with T2DM.
引用
收藏
页码:859 / 864
页数:6
相关论文
共 50 条
  • [1] Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses
    Li, Zhibin
    Lin, Mingzhu
    Liu, Changqin
    Wang, Dongmei
    Shi, Xiulin
    Chen, Zheng
    Liu, Yongwen
    Yang, Shuyu
    Li, Xuejun
    CYTOKINE, 2018, 108 : 145 - 150
  • [2] Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
    Cui, Zhengsen
    Xuan, Rong
    Yang, Yunmei
    ONCOTARGET, 2017, 8 (63): : 107149 - 107156
  • [3] Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients
    Yu, Haifeng
    Zhao, Ling
    Liu, Lijuan
    Li, Yanfang
    Sun, Jing
    Liu, Youde
    MEDICINE, 2021, 100 (33)
  • [4] Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease
    Lee, Maosheng
    Peng, Siping
    Xiao, Xiaohui
    Li, Zengying
    Zhao, Hengxia
    Li, Huilin
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [5] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [6] Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study
    Zhu, Jinzhou
    Wan, Xingyong
    Wang, Yuming
    Zhu, Kefu
    Li, Chunxiao
    Yu, Chaohui
    Li, Youming
    ENDOCRINE, 2017, 56 (01) : 208 - 211
  • [7] Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study
    Jinzhou Zhu
    Xingyong Wan
    Yuming Wang
    Kefu Zhu
    Chunxiao Li
    Chaohui Yu
    Youming Li
    Endocrine, 2017, 56 : 208 - 211
  • [8] Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease
    Trojak, Aleksandra
    Walus-Miark, Malgorzata
    Kapusta, Maria
    Miarka, Przemyslaw
    Kawalec, Ewa
    Idzior-Walu, Barbara
    Malecki, Maciej T.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (7-8): : 499 - 505
  • [9] Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
    Sun, Tiantian
    Wang, Chang
    Huo, Lijing
    Wang, Yichao
    Liu, Ke
    Wei, Changmei
    Zhao, Hang
    Chen, Shuchun
    Ren, Luping
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 631 - 639
  • [10] Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease
    Yilmaz, Yusuf
    Eren, Fatih
    Yonal, Oya
    Polat, Zulfikar
    Bacha, Mohammad
    Kurt, Ramazan
    Ozturk, Oguzhan
    Avsar, Erol
    DISEASE MARKERS, 2011, 31 (04) : 205 - 210